Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePREPrenetics Global$14.26-3.7%$9.74$3.09▼$15.45$183.93M0.3445,141 shs17,999 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePREPrenetics Global+2.99%+1.44%+57.72%+89.39%+253.46%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePREPrenetics Global$14.26-3.7%$9.74$3.09▼$15.45$183.93M0.3445,141 shs17,999 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePREPrenetics Global+2.99%+1.44%+57.72%+89.39%+253.46%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePREPrenetics Global 2.00Hold$9.00-36.88% DownsideCurrent Analyst Ratings BreakdownLatest RBW, SOLG, PRE, and GFM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025PREPrenetics GlobalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025PREPrenetics GlobalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPREPrenetics Global$57.05M3.25N/AN/A$13.20 per share1.08Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePREPrenetics Global-$46.30M-$3.99N/AN/AN/A-87.92%-31.05%-24.16%11/26/2025 (Estimated)Latest RBW, SOLG, PRE, and GFM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/12/2025Q2 2025PREPrenetics GlobalN/A-$0.82N/A-$0.94N/A$17.68 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthPREPrenetics Global$2.8019.64%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPREPrenetics GlobalN/A2.162.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipPREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePREPrenetics Global112.99 million11.97 millionNot OptionableRBW, SOLG, PRE, and GFM HeadlinesRecent News About These CompaniesPrenetics: A Cautious Buy Based On Strong Sales GrowthOctober 9 at 2:04 AM | seekingalpha.comPrenetics’ IM8 launches Daily Ultimate Longevity from its IM8 Health brandOctober 8 at 7:54 PM | msn.comPrenetics’ IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of AgingOctober 8 at 7:54 PM | markets.businessinsider.comPrenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of AgingOctober 8 at 8:18 AM | globenewswire.comPrenetics completes $72M ACT Genomics exitOctober 8 at 3:00 AM | msn.comPrenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate ...October 7 at 12:53 PM | bakersfield.comBPrenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8’s Path to $100 Million ARROctober 7 at 12:53 PM | markets.businessinsider.comPrenetics Global Limited Bolsters Financial Strength with $60 Million in Cash and Accelerates Growth of IM8 Supplement BrandOctober 7 at 8:51 AM | quiverquant.comQPrenetics Global Limited (NASDAQ:PRE) Sees Significant Drop in Short InterestOctober 5, 2025 | marketbeat.comPrenetics Global (PRE) to Release Quarterly Earnings on MondayOctober 4, 2025 | americanbankingnews.comPrenetics Global (PRE) Price Target Increased by 85.71% to 26.52September 30, 2025 | msn.comPrenetics Announces CEO Danny Yeung Keynote at Token 2049 SingaporeSeptember 30, 2025 | globenewswire.comPrenetics Global (PRE) Projected to Post Quarterly Earnings on MondaySeptember 29, 2025 | marketbeat.comCONTANGO ORE CLOSES $50 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTSSeptember 26, 2025 | prnewswire.comAre You Looking for a Top Momentum Pick? Why Prenetics Global Limited (PRE) is a Great ChoiceSeptember 25, 2025 | zacks.comEquities Analysts Offer Predictions for PRE FY2025 EarningsSeptember 20, 2025 | marketbeat.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Expands By 52.1%September 16, 2025 | marketbeat.comPrenetics Global (NASDAQ:PRE) Posts Quarterly Earnings ResultsSeptember 14, 2025 | marketbeat.comPrenetics Global Second Quarter 2025 Earnings: Misses ExpectationsSeptember 13, 2025 | finance.yahoo.comPrenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s EndSeptember 13, 2025 | taiwannews.com.twTPrenetics Global Limited: Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's EndSeptember 12, 2025 | finanznachrichten.deMedia Sentiment Over Time Top HeadlinesView All HeadlinesNew Catalysts Build Positive Pressure on Intel StockBy Jeffrey Neal Johnson | September 18, 2025AutoZone Pulls Into a Buy-the-Dip OpportunityBy Thomas Hughes | September 24, 2025Vertical Aerospace Presents Its Blueprint for Sector LeadershipBy Jeffrey Neal Johnson | September 23, 2025Intel's Silent Comeback: 3 Pillars the Market Is OverlookingBy Jeffrey Neal Johnson | September 12, 2025General Mills Is a Generational Opportunity for Income InvestorsBy Thomas Hughes | September 18, 2025RBW, SOLG, PRE, and GFM Company DescriptionsPrenetics Global NASDAQ:PRE$14.26 -0.55 (-3.72%) As of 11:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Adobe Launches Premiere Pro on iPhone, Upside Ahead? Rocket Lab: A Space Giant Hitting New Highs—Time to Chase? After AI Hyperscaler Deal, Is Aehr Test Systems Stock on Sale? Why Archer Aviation Stock Is Soaring—And What Comes Next Lithium Americas: Why This 31% Rally Is More Than Just a Headline Energy Transfer's New Growth Engine Ignites Investor Interest AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal AMD and OpenAI: A Partnership That Just Redrew the AI Map Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
